BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35427454)

  • 1. Anti-viral activity of thiazole derivatives: an updated patent review.
    Farghaly TA; Alsaedi AMR; Alenazi NA; Harras MF
    Expert Opin Ther Pat; 2022 Jul; 32(7):791-815. PubMed ID: 35427454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazole Compounds as Antiviral Agents: An Update.
    Singh IP; Gupta S; Kumar S
    Med Chem; 2020; 16(1):4-23. PubMed ID: 31203807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel thiazole derivatives: a patent review (2008 - 2012; Part 1).
    Leoni A; Locatelli A; Morigi R; Rambaldi M
    Expert Opin Ther Pat; 2014 Feb; 24(2):201-16. PubMed ID: 24215328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Activity of Pyrimidine Containing Compounds: Patent Review.
    Farghaly TA; Harras MF; Alsaedi AMR; Thakir HA; Mahmoud HK; Katowah DF
    Mini Rev Med Chem; 2023; 23(7):821-851. PubMed ID: 36545712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel thiazole derivatives: a patent review (2008 - 2012. Part 2).
    Leoni A; Locatelli A; Morigi R; Rambaldi M
    Expert Opin Ther Pat; 2014 Jul; 24(7):759-77. PubMed ID: 24745553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-Host Interactions: New Insights and Advances in Drug Development Against Viral Pathogens.
    Prasad M; Ranjan K; Brar B; Shah I; Lalmbe U; Manimegalai J; Vashisht B; Gaury M; Kumar P; Khurana SK; Prasad G; Rawat J; Yadav V; Kumar S; Rao R
    Curr Drug Metab; 2017; 18(10):942-970. PubMed ID: 28952435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive review on the antiviral activities of chalcones.
    Elkhalifa D; Al-Hashimi I; Al Moustafa AE; Khalil A
    J Drug Target; 2021 Apr; 29(4):403-419. PubMed ID: 33232192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of cationic amphiphilic drugs.
    Salata C; Calistri A; Parolin C; Baritussio A; Palù G
    Expert Rev Anti Infect Ther; 2017 May; 15(5):483-492. PubMed ID: 28286997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoids in the therapy and prophylaxis of flu: a patent review.
    Costa SS; Couceiro JN; Silva IC; Malvar Ddo C; Coutinho MA; Camargo LM; Muzitano MF; Vanderlinde FA
    Expert Opin Ther Pat; 2012 Oct; 22(10):1111-21. PubMed ID: 22971104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral therapies.
    Hallenberger S
    J Clin Virol; 2004 Apr; 30 Suppl 1():S23-5. PubMed ID: 15062765
    [No Abstract]   [Full Text] [Related]  

  • 11. Human viral diseases: what is next for antiviral drug discovery?
    De Clercq E
    Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current progress in antiviral strategies.
    Lou Z; Sun Y; Rao Z
    Trends Pharmacol Sci; 2014 Feb; 35(2):86-102. PubMed ID: 24439476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What clinicians need to know about antiviral drugs and viral resistance.
    Hodinka RL
    Infect Dis Clin North Am; 1997 Dec; 11(4):945-67. PubMed ID: 9421709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review.
    Akram M; Tahir IM; Shah SMA; Mahmood Z; Altaf A; Ahmad K; Munir N; Daniyal M; Nasir S; Mehboob H
    Phytother Res; 2018 May; 32(5):811-822. PubMed ID: 29356205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antiviral resistance across acute and chronic viral infections.
    Mason S; Devincenzo JP; Toovey S; Wu JZ; Whitley RJ
    Antiviral Res; 2018 Oct; 158():103-112. PubMed ID: 30086337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Activity Exerted by Natural Products against Human Viruses.
    Musarra-Pizzo M; Pennisi R; Ben-Amor I; Mandalari G; Sciortino MT
    Viruses; 2021 May; 13(5):. PubMed ID: 34064347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal and Therapeutic Potential of Herbs and Plant Metabolites / Extracts Countering Viral Pathogens - Current Knowledge and Future Prospects.
    Dhama K; Karthik K; Khandia R; Munjal A; Tiwari R; Rana R; Khurana SK; Sana Ullah ; Khan RU; Alagawany M; Farag MR; Dadar M; Joshi SK
    Curr Drug Metab; 2018; 19(3):236-263. PubMed ID: 29380697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intervention strategies for emerging viruses: use of antivirals.
    Debing Y; Jochmans D; Neyts J
    Curr Opin Virol; 2013 Apr; 3(2):217-24. PubMed ID: 23562753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses.
    Sukmarini L
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35565968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
    Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.